These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15340159)

  • 1. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice.
    Jin K; Galvan V; Xie L; Mao XO; Gorostiza OF; Bredesen DE; Greenberg DA
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13363-7. PubMed ID: 15340159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term environmental enrichment rescues adult neurogenesis and memory deficits in APP(Sw,Ind) transgenic mice.
    Valero J; España J; Parra-Damas A; Martín E; Rodríguez-Álvarez J; Saura CA
    PLoS One; 2011 Feb; 6(2):e16832. PubMed ID: 21347380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice.
    Gan L; Qiao S; Lan X; Chi L; Luo C; Lien L; Yan Liu Q; Liu R
    Neurobiol Dis; 2008 Jan; 29(1):71-80. PubMed ID: 17916429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
    Zeng Q; Zheng M; Zhang T; He G
    Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice.
    Niidome T; Taniuchi N; Akaike A; Kihara T; Sugimoto H
    Neuroreport; 2008 Sep; 19(14):1361-4. PubMed ID: 18766011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
    Hamilton A; Holscher C
    Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
    Liu H; Xue X; Shi H; Qi L; Gong D
    Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
    Rockenstein E; Mante M; Adame A; Crews L; Moessler H; Masliah E
    Acta Neuropathol; 2007 Mar; 113(3):265-75. PubMed ID: 17131129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model.
    Rodríguez JJ; Jones VC; Verkhratsky A
    Neuroreport; 2009 Jul; 20(10):907-12. PubMed ID: 19494789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's disease.
    Shruster A; Offen D
    Behav Brain Res; 2014 Mar; 261():193-201. PubMed ID: 24388979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology.
    Herring A; Ambrée O; Tomm M; Habermann H; Sachser N; Paulus W; Keyvani K
    Exp Neurol; 2009 Mar; 216(1):184-92. PubMed ID: 19118549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model.
    Kamphuis W; Orre M; Kooijman L; Dahmen M; Hol EM
    Glia; 2012 Apr; 60(4):615-29. PubMed ID: 22262260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
    Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
    Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel phosphodiesterase-5 Inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice model.
    Zhu L; Yang JY; Xue X; Dong YX; Liu Y; Miao FR; Wang YF; Xue H; Wu CF
    Mech Ageing Dev; 2015 Sep; 150():34-45. PubMed ID: 26200391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.